1. Cruz-Jentoft AJ, Landi F, Schneider SM, et al (2014) Prevalence of and interventions for sarcopenia in ageing adults: A systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing 43:48–759 . doi: https://doi.org/10.1093/ageing/afu115
2.2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39:412–423 . doi: https://doi.org/10.1093/ageing/afq034
Article PubMed PubMed Central Google Scholar
3.3. Beaudart C, Rizzoli R, Bruyère O, et al (2014) Sarcopenia: burden and challenges for public health. Arch Public Heal 72:45 . doi: https://doi.org/10.1186/2049-3258-72-45
4.4. Cruz-Jentoft AJ, Sayer AA (2019) Sarcopenia. Lancet 393:2636–2646
5.5. Cruz-Jentoft AJ, Bahat G, Bauer J, et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31 . doi: https://doi.org/10.1093/ageing/afy169
6.6. Wall BT, Dirks ML, Van Loon LJC (2013) Skeletal muscle atrophy during short-term disuse: Implications for age-related sarcopenia. Ageing Res. Rev. 12:898–906
7.7. Lenchik L, Boutin RD (2018) Sarcopenia: Beyond Muscle Atrophy and into the New Frontiers of Opportunistic Imaging, Precision Medicine, and Machine Learning. Semin Musculoskelet Radiol 22:307–322 . doi: https://doi.org/10.1055/s-0038-1641573
8.8. Ali S, Garcia JM (2014) Sarcopenia, cachexia and aging: Diagnosis, mechanisms and therapeutic options - A mini-review. Gerontology 60:294–305
9.9. Verdijk LB, Snijders T, Drost M, et al (2014) Satellite cells in human skeletal muscle; from birth to old age. Age (Omaha) 36:545–557 . doi: https://doi.org/10.1007/s11357-013-9583-2
10.10. Vitale JA, Bonato M, Borghi S, et al (2020) Home-based resistance training for older subjects during the COVID-19 outbreak in Italy: Preliminary results of a six-months RCT. Int J Environ Res Public Health 17:9533 . doi: https://doi.org/10.3390/ijerph17249533
CAS Article PubMed Central Google Scholar
11.11. Ciciliot S, Rossi AC, Dyar KA, et al (2013) Muscle type and fiber type specificity in muscle wasting. Int. J. Biochem. Cell Biol. 45:2191–2199
12.12. Manini TM, Hong SL, Clark BC (2013) Aging and muscle: A neuron?s perspective. Curr. Opin. Clin. Nutr. Metab. Care 16:21–26
13.13. Brioche T, Pagano AF, Py G, Chopard A (2016) Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention. Mol Aspects Med 50:56–87 . doi: https://doi.org/10.1016/j.mam.2016.04.006
CAS Article PubMed Google Scholar
14.14. Hirschfeld HP, Kinsella R, Duque G (2017) Osteosarcopenia: where bone, muscle, and fat collide. Osteoporos. Int. 28:2781–2790
15.15. Kalinkovich A, Livshits G (2017) Sarcopenic obesity or obese sarcopenia: A cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res. Rev. 35:200–221
16.16. Vitale JA, Messina C, Albano D, et al (2021) Appendicular Muscle Mass, Thigh Intermuscular Fat Infiltration, and Risk of Fall in Postmenopausal Osteoporotic Elder Women. Gerontology 67:415-424. doi: https://doi.org/10.1159/000513597
17.17. Barazzoni R, Bischoff SC, Boirie Y, et al (2018) Sarcopenic obesity: Time to meet the challenge. Clin Nutr 37:1787–1793 . doi: https://doi.org/10.1016/j.clnu.2018.04.018
18.18. Scott D, Sanders KM, Aitken D, et al (2014) Sarcopenic obesity and dynapenic obesity: 5-year associations with falls risk in middle-aged and older adults. Obesity 22:1568–1574 . doi: https://doi.org/10.1002/oby.20734
19.19. Lee K, Shin Y, Huh J, et al (2019) Recent issues on body composition imaging for sarcopenia evaluation. Korean J. Radiol. 20:205–217
20.20. Dankbar B, Fennen M, Brunert D, et al (2015) Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med 21:1085–1090 . doi: https://doi.org/10.1038/nm.3917
CAS Article PubMed Google Scholar
21.21. Messina C, Monaco CG, Ulivieri FM, et al (2016) Dual-energy X-ray absorptiometry body composition in patients with secondary osteoporosis. Eur J Radiol 85:1493–1498 . doi: https://doi.org/10.1016/j.ejrad.2016.03.018
22.22. Cochenski Borba VZ, Costa TL, Moreira CA, Boguszewski CL (2019) Mechanisms of endocrine disease sarcopenia in endocrine and non-endocrine disorders. Eur. J. Endocrinol. 180:R185–R199
23.23. Kalyani RR, Corriere M, Ferrucci L (2014) Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2:819–829
24.24. Schiaffino S, Albano D, Cozzi A, et al (2021) CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19. Radiology 300:E328-E336. doi: https://doi.org/10.1148/radiol.2021204141
25.25. Ryan E, McNicholas D, Creavin B, et al (2019) Sarcopenia and inflammatory bowel disease: A systematic review. Inflamm. Bowel Dis. 25:67–73
26.26. Bamba S, Sasaki M, Takaoka A, et al (2017) Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn’s disease. PLoS One 12:e0180036 . doi: https://doi.org/10.1371/journal.pone.0180036
CAS Article PubMed PubMed Central Google Scholar
27.27. Barone M, Viggiani M, Anelli M, et al (2018) Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors. J Clin Med 7:504 . doi: https://doi.org/10.3390/jcm7120504
Article PubMed Central Google Scholar
28.28. McKee A, Morley JE, Matsumoto AM, Vinik A (2017) Sarcopenia: An endocrine disorder? Endocr. Pract. 23:1143–1152
29.29. Kuan LL, Dennison AR, Garcea G (2021) Prevalence and Impact of Sarcopenia in Chronic Pancreatitis: A Review of the Literature. World J. Surg. 45:590–597
30.30. Anjanappa M, Corden M, Green A, et al (2020) Sarcopenia in cancer: Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol 16:50–57 . doi: https://doi.org/10.1016/j.tipsro.2020.10.001
Article PubMed PubMed Central Google Scholar
31.Gourd E (2018) Sarcopenia and adiposity linked to overall survival. Lancet. Oncol. 19:e239
32.32. Prado CMM, Lima ISF, Baracos VE, et al (2011) An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity. Cancer Chemother Pharmacol 67:93–101 . doi: https://doi.org/10.1007/s00280-010-1288-y
CAS Article PubMed Google Scholar
33.33. Babu JM, Kalagara S, Durand W, et al (2019) Sarcopenia as a Risk Factor for Prosthetic Infection After Total Hip or Knee Arthroplasty. J Arthroplasty 34:116–122 . doi: https://doi.org/10.1016/j.arth.2018.09.037
34.34. de Jong MC, Patel N, Hassan-Smith Z, et al (2021) Sarcopenia is Associated with Reduced Survival following Surgery for Adrenocortical Carcinoma. Endocr Res 1–10 . doi: https://doi.org/10.1080/07435800.2021.1954942
35.35. Chakedis J, Spolverato G, Beal EW, et al (2018) Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers. J Gastrointest Surg 22:1697–1708 . doi: https://doi.org/10.1007/s11605-018-3802-1
36.36. Sakurai K, Kubo N, Tamamori Y, et al (2021) Depletion of skeletal muscle mass adversely affects long-term outcomes for men undergoing gastrectomy for gastric cancer. PLoS One 16:e0256365 . doi: https://doi.org/10.1371/journal.pone.0256365
CAS Article PubMed PubMed Central Google Scholar
37.37. Mijnarends DM, Schols JMGA, Meijers JMM, et al (2015) Instruments to Assess Sarcopenia and Physical Frailty in Older People Living in a Community (Care) Setting: Similarities and Discrepancies. J Am Med Dir Assoc 16:301–308 . doi: https://doi.org/10.1016/j.jamda.2014.11.011
38.38. Al-Gindan YY, Hankey C, Govan L, et al (2014) Derivation and validation of simple equations to predict total muscle mass from simple anthropometric and demographic data. Am J Clin Nutr 100:1041–1051 . doi: https://doi.org/10.3945/ajcn.113.070466
CAS Article PubMed PubMed Central Google Scholar
39.Faes TJC, Van Der Meij HA, De Munck JC, Heethaar RM (1999) The electric resistivity of human tissues (100 HZ-10 MHZ): A meta- analysis of review studies. Physiol. Meas. 20
40.40. Tosato M, Marzetti E, Cesari M, et al (2017) Measurement of muscle mass in sarcopenia: from imaging to biochemical markers. Aging Clin Exp Res 29:19–27 . doi: https://doi.org/10.1007/s40520-016-0717-0
41.41. Yoshida D, Suzuki T, Shimada H, et al (2014) Using two different algorithms to determine the prevalence of sarcopenia. Geriatr Gerontol Int 14:46–51 . doi: https://doi.org/10.1111/ggi.12210
42.42. Albano D, Messina C, Vitale J, Sconfienza LM (2019) Imaging of sarcopenia: old evidence and new insights. Eur Radiol 30:2199–2208 . doi: https://doi.org/10.1007/s00330-019-06573-2
43.43. Messina C, Albano D, Gitto S, et al (2020) Body composition with dual energy X-ray absorptiometry: from basics to new tools. Quant Imaging Med Surg 10:1687–1698 . doi: https://doi.org/10.21037/qims.2020.03.02
Article PubMed PubMed Central Google Scholar
44.44. Guglielmi G, Ponti F, Agostini M, et al (2016) The role of DXA in sarcopenia. Aging Clin. Exp. Res. 28:1047–1060
45.45. Messina C, Maffi G, Vitale JA, et al (2018) Diagnostic imaging of osteoporosis and sarcopenia: A narrative review. Quant. Imaging Med. Surg. 8:86–99
46.46. Prado CMM, Heymsfield SB (2014) Lean tissue imaging: A new era for nutritional assessment and intervention. J Parenter Enter Nutr 38:940–953 . doi: https://doi.org/10.1177/0148607114550189
留言 (0)